STUDYING THE CHRONIC TOXICITY OF THE NEW DRUG "TIOСIN" IN PRECLINICAL PRACTICE

Authors

  • Boboyev Behzod Muminjon ugli Free applicant of the Department of Clinical Pharmacology of the Tashkent Medical Academy
  • Allayeva Munira Jurakulovna Professor, Head of the Department of Clinical Pharmacology, Tashkent Medical Academy

Abstract

Dyslipidemia is a violation of lipoprotein metabolism, manifested by an increase in cholesterol, triglyceride levels. Dyslipidemia is a potential risk factor for further development of cardiovascular disease.

Downloads

Published

2023-08-01

Issue

2023: 16th ICARHSE-Usa July

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

STUDYING THE CHRONIC TOXICITY OF THE NEW DRUG "TIOСIN" IN PRECLINICAL PRACTICE. (2023). Conferencea , 84-86. https://conferencea.org/index.php/conferences/article/view/2761

Most read articles by the same author(s)